An "EmbraceMe" Self-compassion Intervention for Transgender and Gender-diverse People in Hong Kong
2 other identifiers
interventional
70
1 country
1
Brief Summary
This proposed pilot study aims to evaluate the "EmbraceMe", a self-compassion intervention to improve positive body image and mental health among transgender and gender-diverse (TGD) people in Hong Kong.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 28, 2026
CompletedFirst Posted
Study publicly available on registry
September 9, 2026
CompletedStudy Start
First participant enrolled
November 1, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2028
Study Completion
Last participant's last visit for all outcomes
April 30, 2028
September 9, 2026
September 1, 2026
1.5 years
August 28, 2026
September 2, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Feasibility outcomes
Completion rate: In each group, the completion rate is defined as the number of participants who complete outcome measurements at immediate post-intervention and 3-month follow-up divided by those who are randomized.
Baseline; immediately after the intervention; 3-month post-intervention.
Secondary Outcomes (7)
Acceptability
Immediately after the intervention
Self-compassion
Baseline; immediately after the intervention; 3-month post-intervention.
Internalized stigma
Baseline; immediately after the intervention; 3-month post-intervention.
Self-esteem
Baseline; immediately after the intervention; 3-month post-intervention.
Body appreciation
Baseline; immediately after the intervention; 3-month post-intervention.
- +2 more secondary outcomes
Study Arms (2)
"EmbraceMe" intervention group
EXPERIMENTALParticipants in the "EmbraceMe" intervention group will receive group-based self-compassion intervention comprising five consecutive weekly sessions, with each session lasting 2 hours (totaling 10 hours).
Waiting-list control group
NO INTERVENTIONParticipants in the waiting-list control group will receive the "EmbraceMe" intervention after thecompletion of the intervention at a 3-month follow-up.
Interventions
Participants in the "EmbraceMe" intervention group will receive group-based self-compassion intervention comprising five consecutive weekly sessions, with each session lasting 2 hours (totaling 10 hours). Each session will include an introduction, guided exercises, group discussions and home practice.
Eligibility Criteria
You may qualify if:
- aged 18 years or above;
- self-identified as a transgender and gender-diverse (TGD) individual;
- sufficient comprehension of Cantonese;
- currently livein Hong Kong;
- able to provide informed consent.
You may not qualify if:
- currently experiencing psychosis;
- having an intellectual disability;
- experiencing current suicidal ideation (score ≥ 4) as measured using the Columbiasuicide severity rating scale
- currently enrolled in or have previously received similarservices or interventions.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
School of Nursing and Health Sciences, Hong Kong Metropolitan University
Hong Kong, 999077, Hong Kong
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Haixia MA, PhD
School of Nursing and Health Sciences, Hong Kong Metropolitan University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
August 28, 2026
First Posted
September 9, 2026
Study Start (Estimated)
November 1, 2026
Primary Completion (Estimated)
April 30, 2028
Study Completion (Estimated)
April 30, 2028
Last Updated
September 9, 2026
Record last verified: 2026-09
Data Sharing
- IPD Sharing
- Will not share
Due to the sensitive nature of the participant population (transgender and gender-diverse individuals), we will only share the individual participant data (IPD) that directly underpin the results presented in the publication.